This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Intelligent Bio Solutions reported a Q3 loss of 44 cents per share with a 20% revenue rise from Q2 and 91% year-over-year ...

This expected patent will enhance INBS’ existing intellectual property ... public offering of 1,500,000 shares of common stock at a public offering price of $2.00 per share of common stock ...

Likely Trend of INBS Stock Following the News Following the announcement, shares of the company tumbled 5.1% and closed at $1.67 yesterday. In the past six months, INBS’ shares have lost 8.2% ...

Intelligent Bio Solutions Partners With CenEx ...

By incorporating Latin American Spanish into the System, INBS strengthens its support for Spanish-speaking markets and regional distribution partners. This update increases accessibility for end-users ...

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential r ...

ultimately boosting the performance of the INBS stock over time. Meanwhile, INBS currently has a market capitalization of $11.9 billion. The company expects an earnings growth of 80.4% in 2025.

1 Day INBS -3.12% DJIA 0.75% Russell 2K 0.56% Health Care/Life Sciences -0.80% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...